3 ms·
a) Let's say you vaccinate all south-africans with AZ+Moderna+JJ+PB, then 1/4 of the population will be barely protected. b) Let's say you vaccinate all south-
by hobbes78 6y ago
a) Let's say you vaccinate all south-africans with AZ+Moderna+JJ+PB, then 1/4 of the population will be barely protected.
b) Let's say you vaccinate all south-africans with Moderna+JJ+PB, then all the population will be protected.
If you pay the same in both scenarios, why on earth would you choose a)?
- bluGill 6y agoBecause vaccines are in short supply. The choice isn't AZ+Moderna+JJ+PB vs Moderna+JJ+PB. the real choice today is AZ+Moderna+JJ+PB+NOTHING vs Moderna+JJ+PB+NOTHING, with the size of nothing being larger in the second case. So really it is c: you vaccinate everyone with whatever you can get your hands on. Once everyone has had some vaccine you look at data of what is working and give everyone with a less effective vaccine an additional dose of whatever works - which will probably be a new vaccine that doesn't exist yet! Don't forget that mutations are continuous. We might be looking at another mutation in 3 months as supply catches up that evades vaccines in a completely new way.
- zeku 6y agoTo be fair the article claims they will have other vaccines available in a couple of weeks.
- mannykannot 6y agoThat works both ways: the sooner the alternatives are available in adequate quantities, the less the harm (if there is anything to be concerned about) of continuing to use the AZ vaccine at least until then.
- bluGill 6y agoFair point, but the others won't be available in adequate quantities anytime soon. I'm not sure where SA stacks up, but nobody is getting adequate quantities before this summer at best.
- curryst 6y ago> give everyone with a less effective vaccine an additional dose of whatever works - which will probably be a new vaccine that doesn't exist yet! I would be careful about assuming that's an option. The vaccines have been tested individually, but have not been tested together. It's not out of the realm of possibility that getting some combination triggers some kind of immune reaction or something else. > Don't forget that mutations are continuous. We might be looking at another mutation in 3 months as supply catches up that evades vaccines in a completely new way. This is, sadly, a reason for poorer countries to delay vaccination. If there's going to be a mutation that evades this vaccine, and you can only afford one round of vaccines for everyone, you'd be better off waiting for the vaccine that prevents both. Based on the last article about this, SA doesn't have the money to do 2 rounds of vaccines. A lot of the money was spent suspiciously, but now funding is limited. It seems that anyone who gets a subpar vaccine is just going to be stuck with subpar coverage.
- mannykannot 6y agoAs a) is likely to reduce the serious cases faster, that seems like a point in its favor. One complication might be if people getting mild cases end up spreading the variant faster, because they are not incapacitated by it - but it is not as if it is having much difficulty spreading now, despite the serious cases it creates, as it seems to spread before it incapacitates. I don't think this possibility demands that we stop using this vaccine until this issue is unequivocally settled.
- deleted 6y ago[deleted]